0001178913-22-004124.txt : 20221228 0001178913-22-004124.hdr.sgml : 20221228 20221122160416 ACCESSION NUMBER: 0001178913-22-004124 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MediWound Ltd. CENTRAL INDEX KEY: 0001593984 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 42 HAYARKON STREET CITY: YAVNE STATE: L3 ZIP: 8122745 BUSINESS PHONE: 97289324010 MAIL ADDRESS: STREET 1: 42 HAYARKON STREET CITY: YAVNE STATE: L3 ZIP: 8122745 CORRESP 1 filename1.htm

MediWound Ltd.
42 Hayarkon Street
Yavne 8122745, Israel 

November 22, 2022
 
VIA EDGAR
 
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Joshua Gorsky
 
Re:
MediWound Ltd.
 
Registration Statement on Form F-1
Filed November 10, 2022
File No. 333-268297 (the “Registration Statement”)
 
Request for Acceleration
 
Ladies and Gentlemen:
 
Pursuant to Rule 460 and 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, MediWound Ltd. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 5:00 p.m., Eastern Time, on November 25, 2022, or as soon thereafter as practicable.
 
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Michael J. Rosenberg, Esq. of Latham & Watkins LLP at (212) 906-1829.
 
 
Very truly yours,
 
 
 
MEDIWOUND LTD.
 
 
 
 
By:
/s/ Ofer Gonen
 
 
Ofer Gonen
 
 
Chief Executive Officer
 
cc:   Michael J. Rosenberg, Esq., Latham & Watkins LLP